This study highlights IFN-γ and TNF-α as inflammatory biomarkers that are independently associated with the risk of MACE within 2 years among individuals diagnosed with PAD, suggesting their potential utility in prognostic assessment. This evidence concerns the gene TNF and peripheral arterial disease.